Skip to main content
Top
Published in: Diabetologia 10/1998

01-09-1998 | Originals

Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells

Authors: K. Almind, L. Ambye, S. A. Urhammer, T. Hansen, S. M. Echwald, J. J. Holst, J. Gromada, B. Thorens, O. Pedersen

Published in: Diabetologia | Issue 10/1998

Login to get access
Metadata
Title
Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells
Authors
K. Almind
L. Ambye
S. A. Urhammer
T. Hansen
S. M. Echwald
J. J. Holst
J. Gromada
B. Thorens
O. Pedersen
Publication date
01-09-1998
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 10/1998
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s001250051051

Other articles of this Issue 10/1998

Diabetologia 10/1998 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.